Contract analysis

I. EXECUTIVE SUMMARY This memorandum analyzes the Irish tax consequences and the United States–Ireland Income Tax Treaty (the "Treaty") implications of the proposed transfer of certain intellectual property assets (the "IP Portfolio") from Solstice Medical Technologies Inc. ("SMT Inc."), a Delaware C-corporation (EIN 84-3291507; Delaware File No. 7482916), to Solstice IP Holdings DAC ("SIP Holdings") (CRO No. 714538)

II. FACTUAL BACKGROUND A. Transaction Parties and Corporate Structure Solstice Biomedical Devices Ltd. ("SBD"). SBD is an Irish private company limited by shares, registered with the Companies Registration Office ("CRO") under CRO No. 587241. SBD's registered office is located at Unit 14, Corrib Technology Park, Headford Road, Galway, H91 XR72, Ireland. SBD's principal business is the design, manufacture, and distrib

III. SECTION 291A TCA 1997 — CAPITAL ALLOWANCES ON SPECIFIED INTANGIBLE ASSETS A. Overview of the Irish Intangible Asset Amortization Regime

Section 291A of the Taxes Consolidation Act 1997 provides a statutory framework under which Irish-resident companies may claim capital allowances (i.e., tax depreciation) on qualifying expenditure incurred on the acquisition of "specified intangible assets" for the purposes of a trade carried on by the company. This regime, commonly referred to as the "knowledge development box" capital allowances regime (though dist

IV. IRISH TRANSFER PRICING COMPLIANCE A. Overview of Irish TP Rules — Finance Act 2019 Amendments Ireland's transfer pricing regime underwent a significant overhaul as part of the Finance Act 2019, which introduced comprehensive amendments to Part 35A of the TCA 1997, effective for chargeable periods commencing on or after January 1, 2020. The amended rules represent a substantial expansion and modernization of Irela

Section 835E TCA 1997, as introduced by Finance Act 2019, imposes mandatory transfer pricing documentation requirements on Irish-resident companies that are parties to arrangements with associated persons. The documentation requirements are broadly aligned with the OECD's three-tier documentation framework: Master File. A master file containing group-level information about the SBD group's organizational structure, b

V. US-IRELAND INCOME TAX TREATY — ROYALTY WITHHOLDING AND LIMITATION ON BENEFITS A. Article 12 — Royalties: Withholding Rate Reduction Statutory Withholding Rate. Under the Internal Revenue Code, royalty payments from a US person to a foreign person are generally classified as "fixed or determinable annual or periodical" ("FDAP") income and are subject to US withholding tax at a statutory rate of 30% under IRC § 1441

1. Ownership and Base Erosion Test (Article 23(2)(e)) The ownership and base erosion test under Article 23(2)(e) of the Treaty generally provides that a company resident in Ireland is a "qualified person" entitled to Treaty benefits if: (i) More than 50% of the beneficial interest in the company (or, in the case of a company with multiple classes of shares, more than 50% of each class) is owned, directly or indirectl

2. Active Trade or Business Test (Article 23(3)) As an alternative to the ownership and base erosion test, SIP Holdings may seek to qualify for Treaty benefits under the active trade or business test in Article 23(3) of the Treaty. This test provides that a resident of Ireland is entitled to Treaty benefits with respect to an item of income derived from the United States if: (i) The resident is engaged in the active